COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #135
Source   PDF   Share   Tweet
See all 146 studies
Late treatment study
Ayerbe et al., Internal and Emergency Medicine, doi:0.1007/s11739-020-02505-x (Peer Reviewed)
The association of treatment with hydroxych loroquine and hospital mortality in COVID-19 patients
2075 hospital patients in Spain showing HC Q reduces mortality 52%, odds ratio OR 0.39, p<0.001, after adjustment for age, gender, temperature > 37 °C, and saturation of oxygen < 90% treatment with azithromycin, steroids, heparin, tocilizumab, a combination of lopinavir with ritonavir, and oseltamivir, and date of admission (model 4).
death, ↓52.2%, p<0.001
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 146 studies
Please send us corrections, updates, or comments.